WASHINGTON, June 17, 2021 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced today that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. Danaher expects to finance the acquisition using cash on hand and/or proceeds from the issuance of commercial paper.
BioND is dedicated to expanding the boundaries of bio-science to commercialize, grow and sustain globally competitive bio-science, companies, creating careers and economic opportunity in North Dakota.
The mission of BioND is bringing forward the entrepreneurial culture into bio-science, biotechnology research and business development in agriculture, life and energy science fields while concurrently growing economic opportunities in North Dakota.
Our vision is to create an entrepreneurial ecosystem which is regarded as a premier location for the creation and growth of bio-science/biotechnology research and enterprise benefiting mankind while stimulating economic development within the state of North Dakota.